Glucocerebrosidase mutations are an important risk factor for Lewy body disorders
Goker-Alpan, O, Giasson, B I, Eblan, M J, Nguyen, J, Hurtig, H I, Lee, V M-Y, Trojanowski, J Q, Sidransky, E
Published in Neurology (12.09.2006)
Published in Neurology (12.09.2006)
Get more information
Journal Article
The Role of Dendritic Cells, B Cells, and M Cells in Gut-Oriented Immune Responses
Alpan, Oral, Rudomen, Gregory, Matzinger, Polly
Published in The Journal of immunology (1950) (15.04.2001)
Published in The Journal of immunology (1950) (15.04.2001)
Get full text
Journal Article
Divergent phenotypes in Gaucher disease implicate the role of modifiers
Goker-Alpan, O, Hruska, K S, Orvisky, E, Kishnani, P S, Stubblefield, B K, Schiffmann, R, Sidransky, E
Published in Journal of medical genetics (01.06.2005)
Published in Journal of medical genetics (01.06.2005)
Get full text
Journal Article
Phenotypic continuum in neuronopathic gaucher disease: an intermediate phenotype between type 2 and type 3
Goker-Alpan, Ozlem, Schiffmann, Raphael, Park, Joseph K, Stubblefield, Barbara K, Tayebi, Nahid, Sidransky, Ellen
Published in The Journal of pediatrics (01.08.2003)
Published in The Journal of pediatrics (01.08.2003)
Get full text
Journal Article
Parkinsonism among Gaucher disease carriers
Goker-Alpan, O, Schiffmann, R, LaMarca, M E, Nussbaum, R L, McInerney-Leo, A, Sidransky, E
Published in Journal of medical genetics (01.12.2004)
Published in Journal of medical genetics (01.12.2004)
Get full text
Journal Article
T.P.24
Thurberg, B.L, van der Ploeg, A, Kissel, J.T, Schoser, B, Pestronk, A, Barohn, R.J, Goker-Alpan, O, Mozaffar, T, Pena, L.D.M, Simmons, Z, Straub, V, Young, P, Bjartmar, C
Published in Neuromuscular disorders : NMD (01.10.2014)
Published in Neuromuscular disorders : NMD (01.10.2014)
Get full text
Journal Article
Uniparental disomy of chromosome 1 causing concurrent Charcot-Marie-Tooth and Gaucher disease Type 3
Benko, W S, Hruska, K S, Nagan, N, Goker-Alpan, O, Hart, P S, Schiffmann, R, Sidransky, E
Published in Neurology (18.03.2008)
Published in Neurology (18.03.2008)
Get more information
Journal Article
T.P.46 A novel phase 2a study design to investigate drug-drug interactions between escalating doses of AT2220 (duvoglustat hydrochloride) and acid alpha-glucosidase in subjects with Pompe disease
Kishnani, P, Tarnopolsky, M, Sivakumar, K, Byrne, B, Goker-Alpan, O, Guter, K, Pervaiz, M, Dasouki, M, Levine, T, Roberts, M, Johnson, F.K, Valenzano, K.J, Lockhart, D.J, Boudes, P
Published in Neuromuscular disorders : NMD (01.10.2012)
Published in Neuromuscular disorders : NMD (01.10.2012)
Get full text
Journal Article
Skin abnormalities as an early predictor of neurologic outcome in Gaucher disease
Holleran, WM, Ziegler, SG, Goker-Alpan, O, Eblan, MJ, Elias, PM, Schiffmann, R, Sidransky, E
Published in Clinical genetics (01.04.2006)
Published in Clinical genetics (01.04.2006)
Get full text
Journal Article
T.P.45 An ongoing phase 2a study to investigate drug–drug interactions between escalating doses of AT2220 (duvoglustat hydrochloride) and acid alpha glucosidase in subjects with Pompe disease – Preliminary results
Kishnani, P, Tarnopolsky, M, Sivakumar, K, Byrne, B, Goker-Alpan, O, Guter, K, Pervaiz, M, Dasouki, M, Levine, T, Roberts, M, Johnson, F.K, Sitaraman, S, Khanna, R, Flanagan, J, Sjoberg, E.R, Valenzano, K.J, Lockhart, D.J, Boudes, P
Published in Neuromuscular disorders : NMD (01.10.2012)
Published in Neuromuscular disorders : NMD (01.10.2012)
Get full text
Journal Article
Clinical Outcomes With Recombinant Human C1 Inhibitor In The Repeat Treatment Of Acute Attacks Of Hereditary Angioedema In North-american Patients
Zuraw, B, Craig, T, Lockey, R.F, Park, M, Grant, J, Suez, D, Schwartz, L.B, Riedl, M, Levy, R.J, Li, H.H, Edara, L, Bernstein, J.A, Moy, J, Offenberger, J, Szema, A, Engler, A, Rehman, S.M, Marbury, T.C, Alpan, O, Bahna, S.L, Davis, A, Sussman, G, Yang, W.H, Ritchie, B, Relan, A
Published in Journal of allergy and clinical immunology (01.02.2011)
Published in Journal of allergy and clinical immunology (01.02.2011)
Get full text
Journal Article
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
Germain, Dominique P, Hughes, Derralynn A, Nicholls, Kathleen, Bichet, Daniel G, Giugliani, Roberto, Wilcox, William R, Feliciani, Claudio, Shankar, Suma P, Ezgu, Fatih, Amartino, Hernan, Bratkovic, Drago, Feldt-Rasmussen, Ulla, Nedd, Khan, Sharaf El Din, Usama, Lourenco, Charles M, Banikazemi, Maryam, Charrow, Joel, Dasouki, Majed, Finegold, David, Giraldo, Pilar, Goker-Alpan, Ozlem, Longo, Nicola, Scott, C. Ronald, Torra, Roser, Tuffaha, Ahmad, Jovanovic, Ana, Waldek, Stephen, Packman, Seymour, Ludington, Elizabeth, Viereck, Christopher, Kirk, John, Yu, Julie, Benjamin, Elfrida R, Johnson, Franklin, Lockhart, David J, Skuban, Nina, Castelli, Jeff, Barth, Jay, Barlow, Carrolee, Schiffmann, Raphael
Published in The New England journal of medicine (11.08.2016)
Published in The New England journal of medicine (11.08.2016)
Get full text
Journal Article
P372 Safety of home administration of cipaglucosidase alfa + miglustat in late-onset Pompe disease: results from multiple clinical trials
Byrne, B., Diaz-Manera, J., Goker-Alpan, O., Mozaffar, T., Wasfi, Y., Das, S Sitaraman, Fox, B., Holdbrook, F., Jain, V.
Published in Neuromuscular disorders : NMD (01.10.2023)
Published in Neuromuscular disorders : NMD (01.10.2023)
Get full text
Journal Article
Catheter-associated fungemia due to Wangiella (Exophiala) dermatitidis
NACHMAN, S, ALPAN, O, MALOWITZ, R, SPITZER, E. D
Published in Journal of Clinical Microbiology (01.04.1996)
Published in Journal of Clinical Microbiology (01.04.1996)
Get full text
Journal Article
FP.17 Long-term follow-up of cipaglucosidase alfa/miglustat in ambulatory patients with Pompe disease: An open-label phase I/II study (ATB200-02)
Schoser, B., Kishnani, P., Bratkovic, D., Clemens, P., Goker-Alpan, O., Ming, X., Roberts, M., Vorgerd, M., Sivakumar, K., van der Ploeg, A., Goldman, M., Wright, J., Holdbrook, F., Jain, V., Sitaraman, S., Wasfi, Y., Mozaffar, T., Byrne, B.
Published in Neuromuscular disorders : NMD (01.10.2022)
Published in Neuromuscular disorders : NMD (01.10.2022)
Get full text
Journal Article